Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension

Rianne A. A. de Heus, Rogier Donders, Angelina M. M. Santoso, Marcel G. M. Olde Rikkert, Brian A. Lawlor, Jurgen A. H. R. Claassen*, Ricardo Segurado, Sean Kennelly, Robert Howard, Florence Pasquier, Anne Borjesson-Hanson, Magda Tsolaki, Ugo Lucca, D. William Molloy, Robert Coen, Matthias W. Riepe, Janos Kalman, Rose Anne Kenny, Fiona Cregg, Sarah O'DwyerCathal Walsh, Jessica Adams, Rita Banzi, Laetitia Breuilh, Leslie Daly, Suzanne Hendrix, Paul Aisen, Siobhan Gaynor, Ali Sheikhi, Diana G. Taekema, Frans R. Verhey, Raffaello Nemni, Flavio Nobili, Massimo Franceschi, Orazio Zanetti, Anastasia Konsta, Orologas Anastasios, Styliani Nenopoulou, Fani Tsolaki-Tagarak, Magdolna Pakaski, Olivier Dereeper, Vincent de la Sayette, Olivier Senechal, Isabelle Lavenu, Agnes Devendeville, Gauthier Calais, Fiona Crawford, Michael Mullan, Pauline Aalten, Maria A. Berglund, NILVAD Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number011938
Number of pages24
JournalJournal of the American Heart Association
Volume8
Issue number10
DOIs
Publication statusPublished - 21 May 2019

Keywords

  • adverse drug event
  • Alzheimer disease
  • antihypertensive agent
  • calcium channel blocker
  • orthostatic hypotension
  • randomized controlled trial
  • ANTIHYPERTENSIVE TREATMENT
  • COGNITIVE IMPAIRMENT
  • CONSENSUS STATEMENT
  • CARDIOVASCULAR RISK
  • EUROPEAN-SOCIETY
  • HYPERTENSION
  • ASSOCIATION
  • MANAGEMENT
  • OLDER
  • DEMENTIA

Cite this

de Heus, R. A. A., Donders, R., Santoso, A. M. M., Rikkert, M. G. M. O., Lawlor, B. A., Claassen, J. A. H. R., Segurado, R., Kennelly, S., Howard, R., Pasquier, F., Borjesson-Hanson, A., Tsolaki, M., Lucca, U., Molloy, D. W., Coen, R., Riepe, M. W., Kalman, J., Kenny, R. A., Cregg, F., ... NILVAD Study Grp (2019). Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension. Journal of the American Heart Association, 8(10), [011938]. https://doi.org/10.1161/JAHA.119.011938